Glimepiride — Nutrient Associations & Health Patterns
Also known as: Glimepiride (Amaryl)
Drug Class: Sulfonylurea (Diabetes medication)
Glimepiride is a Sulfonylurea (Diabetes medication) that may affect nutrient status or medication timing in some contexts. WePattern Pattern Health Intelligence maps evidence-qualified nutrient associations, side effects, and interaction context linked to Glimepiride.
Reported Nutrient Associations for Glimepiride
Peer-reviewed research reports relationships involving the following nutrients. WePattern surfaces them as evidence-qualified associations; they do not establish deficiency, causation, or a fixed timeline for an individual.
- CoQ10
- Vitamin B12
Common Side Effects of Glimepiride
- Hypoglycemia (low blood sugar)
- Weight gain
- Headache
- Nausea
- Dizziness
- Weakness
- Flu-like symptoms
- Hemolytic anemia (rare, especially with G6PD deficiency)
Key Drug Interactions — Glimepiride
Glimepiride has 15 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:
- Insulin
- Fluconazole
- Miconazole
- NSAIDs
- Warfarin
- Beta-blockers (may mask hypoglycemia symptoms)
Frequently Asked Questions
What nutrient associations are reported for Glimepiride?
Glimepiride has reported nutrient associations involving CoQ10, Vitamin B12 in clinical research. This does not establish that every person will become deficient or that the medication caused an individual result.
Which nutrient relationships are mapped for Glimepiride?
WePattern maps reported associations involving: CoQ10, Vitamin B12. The strength, mechanism, dose, duration, and clinical relevance vary, so a clinician or pharmacist should interpret them in context.
What are the side effects of Glimepiride?
Common side effects associated with Glimepiride include: Hypoglycemia (low blood sugar); Weight gain; Headache; Nausea; Dizziness.